Patents by Inventor Torsten Bryld

Torsten Bryld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mediated cellular delivery of LNA oligonucleotides
    Patent number: 8048998
    Abstract: The present invention relates to novel modified oligomeric compounds and to methods of making and using such compounds. The invention further relates to methods of enhancing the cellular uptake of oligomeric compounds comprising conjugating a metal chelator to those.
    Type: Grant
    Filed: January 18, 2008
    Date of Patent: November 1, 2011
    Assignee: Exiqon A/S
    Inventors: Soeren Vestergaard Rasmussen, Torsten Bryld, Soeren Moeller
  • USE OF SHORT OLIGONUCLEOTIDES FOR REAGENT REDUNDANCY EXPERIMENTS IN RNA FUNCTIONAL ANALYSIS
    Publication number: 20100261175
    Abstract: The present invention relates to functional analysis of miRNAs or other short non-coding RNAs involving the use of two or more sequence distinct miRNAs antagonising oligomeric compounds, which enables the reagent redundancy experiments to reduce the risk of reporting false positive effects of miRNA/ncRNA antagonists.
    Type: Application
    Filed: June 12, 2008
    Publication date: October 14, 2010
    Applicant: Exiqon A/S
    Inventors: Soeren Vestergaard Rasmussen, Soeren Moeller, Torsten Bryld
  • MEDIATED CELLULAR DELIVERY OF LNA OLIGONUCLEOTIDES
    Publication number: 20100035968
    Abstract: The present invention relates to novel modified oligomeric compounds and to methods of making and using such compounds. The invention further relates to methods of enhancing the cellular uptake of oligomeric compounds comprising conjugating a metal chelator to those.
    Type: Application
    Filed: January 18, 2008
    Publication date: February 11, 2010
    Applicant: Exiqon A/S
    Inventors: Soeren Vestergaard Rasmussen, Torsten Bryld, Soeren Moeller